Hi Jack. I am in support of Linda’s re-election to the board, but have not said anything about the vote on options for 3 independent members of the board, which is the 3rd vote. I like your idea of having pay or share increases or options connected to share price increases, though I don’t know if that’s ever done in a public company. I’m very much in support of CEO bonuses being connected to share price. But these options are not associated with Linda Powers. They are for Black, Jasinoski, and Malik.
However, I don’t believe as you do that management is largely responsible for the share drop. I think the share drop is largely due to the fact that they are working in an area of science which was not well understood when they started the trial in 2007/8. And I do believe that shorts and naked shorting have played a significant role in driving the price down.But back to the science, what we have learned recently about pseudo progression caused by immunotherapy, it can produce a bulge on a scan that mimics progression for up to 6 months, according to Dr. Liau in a recent talk. I think we will find when they adjudicate incidences of progression in this trial they’ll find that pseudo progression played havoc with the PFS endpoint. If management had ended the trial earlier, we may have failed because scans were indicating disease progression when the bulges were really because of immune cells proliferating the tumor area. I think managementhad expected to end this trial much earlier, but kept pushing the trial out as they learned more about the pseudo progression issue and the long tail benefits of immunotherapy.
I also worry that the price may be held down after topline and before approval, but I think this will be because of legal and illegal shorting. I also wish management would make a move on any illegal market action they have seen, but I’m not sure I want them to divert cash in that direction right now.
I wish I could agree with you that any CEO would have the same interest in raising share prices as we have. My concern about the vote on returning Linda to the board is that hedge funds or BP may have invested in the company with a hostile takeover in mind that would not benefit us, but might benefit them if they want to buy out the company for pennies per share. But nobody else is on the ballet, so perhaps that can’t happen right now.